[ET Net News Agency, 1 March 2023] HANSOH PHARMA (03692) rose 2.98% to HK$14.52,
breaking above the 250-D SMA of HK$14.47.
It hits an intra-day high of HK$14.54, and an intra-day low of HK$14.2. The total shares
traded was 704,000, with a value of HK$10.14m. The active buy/sell ratio is 52:48, with
net buying turnover of HK$305,840. CREDIT SUISSE (HK) SEC accounts for greatest net
responsive buying turnover of HK$1.11m, with volume weighted average price of HK$14.412.
CHINA INV INFO accounts for greatest net responsive selling turnover of HK$878,033, with
volume weighted average price of HK$14.483.
The Hang Seng Index now rose 538 points, or 2.72% to 20,324.
Basic Information
=================
----------------------------------
Nominal 14.520 % Chg +2.98%
High 14.540 Low 14.200
Shares Tr 704,000 Turnover 10.14m
10-D SMA 14.574 %H.V 31.568
20-D SMA 15.094 VWAP 14.410
50-D SMA 15.579 RSI14 41.269
----------------------------------
Status: Breaking above the 250-D SMA, active buy/sell ratio is 52:48, with net buying
turnover of HK$305,840
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 14.52 +2.98
ALI HEALTH (00241) 5.90 +5.36
TRAD CHI MED (00570) 4.11 +0.98
INNOVENT BIO (01801) 39.55 +3.81
JXR (01951) 6.57 +5.29
WUXI BIO (02269) 56.65 +3.56
CHINARES PHARMA (03320) 6.50 +0.78
HYGEIA HEALTH (06078) 59.50 +4.29
JD HEALTH (06618) 57.30 +4.66
AKESO-B (09926) 40.55 +1.37
-----------------------------------------------
(ed)